Literature DB >> 31289482

Regulation of BTG3 by microRNA-20b-5p in non-small cell lung cancer.

Lijun Peng1, Shaobin Li2, Yuchan Li3, Minghui Wan4, Xisheng Fang5,6, Yongxin Zhao7, Wei Zuo8, Yiwen Xuan1.   

Abstract

The present study aimed to evaluate microRNA- 20b-5p (miR-20b-5p) expression in non-small cell lung cancer (NSCLC), and investigate the effects of miR-20b-5p expression on NSCLC cell proliferation and migration. Reverse transcription-quantitative polymerase chain reaction was performed to measure the expression level of miR-20b-5p in NSCLC tissues and cell lines. Cell Counting Kit-8 and wound healing assays were used to measure cell proliferation and migration. A dual-luciferase reporter assay was performed to validate B-cell translocation gene 3 (BTG3) as a target of miR-20b-5p. It was identified that the expression level of miR-20b-5p is elevated in NSCLC tissues and cell lines. miR-20b-5p overexpression was revealed to promote NSCLC cell proliferation and migration. Furthermore, BTG3 was identified as a direct target of miR-20b-5p, and BTG3 overexpression reversed a miR-20b-5p mimic-induced increase in cell proliferation and migration. In summary, the present study revealed that miR-20b-5p promotes NSCLC cell proliferation and migration by targeting BTG3, which may assist with the development of a novel therapeutic target for the treatment of NSCLC.

Entities:  

Keywords:  B-cell translocation gene 3; microRNA-20b-5p; non-small cell lung cancer; oncogene

Year:  2019        PMID: 31289482      PMCID: PMC6539950          DOI: 10.3892/ol.2019.10333

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  9 in total

Review 1.  Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.

Authors:  Rajeswari Raguraman; Akhil Srivastava; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-08-08       Impact factor: 15.470

2.  LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX.

Authors:  Dafeng Xu; Xiangmei Liu; Jincai Wu; Yu Wang; Kailun Zhou; Wenmei Chen; Jiacheng Chen; Cheng Chen; Liang Chen
Journal:  Cancer Biol Ther       Date:  2020-09-15       Impact factor: 4.742

3.  Functional Significance and Therapeutic Potential of miRNA-20b-5p in Esophageal Squamous Cell Carcinoma.

Authors:  Jiarui Yu; Siyuan Chen; Yi Niu; Meiyue Liu; Jie Zhang; Zhao Yang; Peng Gao; Wei Wang; Xiaochen Han; Guogui Sun
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-12       Impact factor: 8.886

4.  Silencing of miR-20b-5p Exerts Inhibitory Effect on Diabetic Retinopathy via Inactivation of THBS1 Gene Induced VEGF/Akt/PI3K Pathway.

Authors:  YanBo Ma; ChunYing Dong; XiHui Chen; RuiXi Zhu; Jie Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-16       Impact factor: 3.168

5.  Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA.

Authors:  Yo Han Lee; Hyun-Jun Jang; Sounkou Kim; Sun Sil Choi; Keon Woo Khim; Hye-Jin Eom; Jimin Hyun; Kyeong Jin Shin; Young Chan Chae; Hongtae Kim; Jiyoung Park; Neung Hwa Park; Chang-Yun Woo; Chung Hwan Hong; Eun Hee Koh; Dougu Nam; Jang Hyun Choi
Journal:  Elife       Date:  2021-12-29       Impact factor: 8.713

6.  microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.

Authors:  Kexin Jiang; Huawei Zou
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

7.  Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers.

Authors:  Ruizhi Wang; Nipun Chopra; Kwangsik Nho; Bryan Maloney; Alexander G Obukhov; Peter T Nelson; Scott E Counts; Debomoy K Lahiri
Journal:  Mol Psychiatry       Date:  2022-01-27       Impact factor: 13.437

8.  The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang; Kai-Hang Shi; Rui Zhang
Journal:  Front Genet       Date:  2022-09-16       Impact factor: 4.772

9.  miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer.

Authors:  Jin-Chun Qi; Zhan Yang; Yan-Ping Zhang; Bao-Sai Lu; Yue-Wei Yin; Kai-Long Liu; Wen-Yong Xue; Chang-Bao Qu; Wei Li
Journal:  Front Oncol       Date:  2020-01-15       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.